Across TCGA patient cohorts, B3GLCT mutation is significantly associated with the RNA expression of many other genes, with 2,970 significant associations in total. UCEC shows the largest number of these associations.

The most reproducible B3GLCT-associated genes across cancer lineages are METTL17, PDP2, and BAG1. Each is linked with B3GLCT in more than 2 cancer types. Because this analysis shows association rather than direction, both B3GLCT-to-partner and partner-to-B3GLCT results are reported.

Each partner links to its own Q-omics profile.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (B3GLCT→partner) and Y-score (partner→B3GLCT) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.

Lineage	Partner gene	X-score	Y-score	p(X)	p(Y)	Sampling consensus	Lineage consensus
UCEC	METTL17 →	+0.409	+3.321	.001	<.001	3	3
UCEC	PDP2 →	+0.577	+2.234	<.001	.001	3	3
UCEC	BAG1 →	+0.482	+3.595	<.001	.001	3	3
UCEC	HSBP1 →	+0.390	+3.708	.003	<.001	3	3
UCEC	RPL26P29 →	+0.358	+2.169	.005	.003	3	2
COAD	MTCO1P56 →	+0.182	+4.109	<.001	.007	3	2

Each partner links to its Q-omics profile. Showing the 6 strongest of 2,970 associations by consensus.

Exploration

B3GLCT survival (RNA) · tumor vs normal (RNA) · all B3GLCT data types